SEC Form 4 · accession 0000315066-18-002123
ViewRay, Inc. · VRAY
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF3,F1 | Aug 2, 2018 | S | 64,900 | $11.95 | D | 1,248,440 | I | F-Prime Capital Partners Healthcare Fund II LP |
| Common StockF4,F1 | Aug 2, 2018 | S | 12,035 | $12.16 | D | 1,236,405 | I | F-Prime Capital Partners Healthcare Fund II LP |
| Common StockF1 | Aug 2, 2018 | S | 2,587 | $12.00 | D | 1,233,818 | I | F-Prime Capital Partners Healthcare Fund II LP |
| Common StockF5,F1 | Aug 3, 2018 | S | 225,153 | $11.25 | D | 1,008,665 | I | F-Prime Capital Partners Healthcare Fund II LP |
| Common StockF6,F1 | Aug 3, 2018 | S | 30,000 | $11.46 | D | 978,665 | I | F-Prime Capital Partners Healthcare Fund II LP |
| Common StockF2 | holding | — | — | — | 1,620 | I | FIMM, LLC |
Table II — derivative securities
Explanation of responses
- F1The general partner of F-Prime Capital Partners Healthcare Fund II LP is F-Prime Capital Partners Healthcare Advisors Fund II LP. F-Prime Capital Partners Healthcare Advisors Fund II LP is solely managed by Impresa Management LLC, its general partner and investment manager. Impresa Management LLC is owned, directly or indirectly, by various shareholders and employees of FMR LLC, including certain members of the Johnson family.
- F2FIMM, LLC is an indirect, wholly-owned subsidiary of FMR LLC.
- F3The price reported for this transaction is the weighted average price of multiple trades at prices ranging from $11.67 to $12.21. FMR LLC hereby undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F4The price reported for this transaction is the weighted average price of multiple trades at prices ranging from $12.15 to $12.18. FMR LLC hereby undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F5The price reported for this transaction is the weighted average price of multiple trades at prices ranging from $11.00 to $11.82. FMR LLC hereby undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F6The price reported for this transaction is the weighted average price of multiple trades at prices ranging from $11.45 to $11.47. FMR LLC hereby undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Remarks
Remark 1: Abigail P. Johnson is a Director, the Chairman and the Chief Executive Officer of FMR LLC. Members of the Johnson family, including Abigail P. Johnson, are the predominant owners, directly or through trusts, of Series B voting common shares of FMR LLC, representing 49% of the voting power of FMR LLC. The Johnson family group and all other Series B shareholders have entered into a shareholders' voting agreement under which all Series B voting common shares will be voted in accordance with the majority vote of Series B voting common shares. Accordingly, through their ownership of voting common shares and the execution of the shareholders' voting agreement, members of the Johnson family may be deemed, under the Investment Company Act of 1940, to form a controlling group with respect to FMR LLC. The address of Abigail P. Johnson is c/o FMR LLC, 245 Summer Street, Boston, MA 02110. Remark 2: Table I, Column 5 does not include shares beneficially owned by FMR Co. Inc., FIAM LLC, and Fidelity Institutional Asset Management Trust Company, each an indirect, wholly-owned subsidiary of FMR LLC, as a result of acting as investment advisers to various investment companies registered under the Investment Company Act of 1940 and other funds and accounts. FMR LLC and Abigail P. Johnson have no pecuniary interest in such shares of Common Stock. Remark 3: The filing of this statement shall not be deemed to be an admission that, for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise, the undersigned are the beneficial owners of any securities reported herein.